Overview

Angiotensin Converting Enzyme Inhibitors in Treatment of Covid 19

Status:
Not yet recruiting
Trial end date:
2029-12-01
Target enrollment:
Participant gender:
Summary
ACEIs as treatment for COVID19
Phase:
Phase 3
Details
Lead Sponsor:
Tanta University
Treatments:
Captopril
Chloroquine
Enalapril